藥物交互作用
Dabigatran etexilate + Erdafitinib
嚴重程度: 嚴重
Dabigatran etexilate and Erdafitinib: major interaction.
最後更新
僅供醫療專業人員參考。本頁為簡要摘要，並非醫療建議，亦不能取代官方仿單或臨床判斷。開立處方或調劑前請務必核實。
本頁的臨床內容僅提供英文版。
摘要
Erdafitinib inhibits P-glycoprotein and may increase the absorption of dabigatran, a P-gp substrate. Higher dabigatran concentrations raise the risk of bleeding, particularly with renal impairment.
用白話說明這項交互作用的意義
Dabigatran etexilate and Erdafitinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Dabigatran etexilate belongs to Cardiovascular; Erdafitinib belongs to Oncology.
為什麼會發生
Inhibition of intestinal P-gp efflux by erdafitinib increases dabigatran bioavailability.
處置方式
If coadministration is unavoidable, take dabigatran at least 6 hours before or after erdafitinib and monitor for bleeding. Check renal function and consider a dabigatran dose reduction or alternative anticoagulant when renal function is impaired.
可向藥師詢問的問題
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Dabigatran etexilate 的其他交互作用
Erdafitinib 的其他交互作用
常見問題
Can I take Dabigatran etexilate with Erdafitinib?
MediHelp rates the interaction as major. Dabigatran etexilate and Erdafitinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Erdafitinib inhibits P-glycoprotein and may increase the absorption of dabigatran, a P-gp substrate. Higher dabigatran concentrations raise the risk of bleeding, particularly with renal impairment.
How serious is the interaction between Dabigatran etexilate and Erdafitinib?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: If coadministration is unavoidable, take dabigatran at least 6 hours before or after erdafitinib and monitor for bleeding. Check renal function and consider a dabigatran dose reduction or alternative anticoagulant when renal function is impaired.
What other medicines interact with Dabigatran etexilate?
MediHelp also lists interactions of Dabigatran etexilate with, for example, Defibrotide, Ketorolac, Mifepristone. The full list is on the Dabigatran etexilate page.
在 MediHelp App 中取得完整藥品專論、劑量資訊與交互作用檢查
在 MediHelp App 中開啟完整參考資料、檢查多種藥物間的交互作用，並使用劑量工具。
